
SPECIAL YEAR-END ADVOCACY ALERT
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
2027 CAC2 Annual Summit. Save the date: June 16–18, 2027 in Louisville, Kentucky. Stay in the know

There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years

During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of

In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on

The October 10 Federal Advocacy drop-in session covered three pieces of authorizing legislation and provided an update on possible appropriations for FY2025. Each of the

By CAC2 Member Autumn Gentry, MACC Fund This collaborative state advocacy effort was due to the dedicated work of a pair of CAC2 members in

At CAC2 we love to celebrate when our members work together. We offer congratulations to Supporting Organization Day One Biopharmaceuticals and CAC2 member authors and

The NCI Council of Research Advocates met virtually on June 26 and heard the latest legislative report, with updates on appropriations, cancer-related legislation, and other

By CAC2 Member Matt Marks (Leukemia & Lymphoma Society) State borders shouldn’t be barriers to treatment for children with cancer or other complex illnesses. Yet

The Energy and Commerce Committee advanced proposals earlier this month that will extend Americans’ access to telehealth services, strengthen and preserve Medicaid, and encourage innovation

CAC2 Board Members invited CAC2 members, associate members, student members, and supporting organizations to our Spring CAC2 All-Member Webinar. The Board encourages you to watch
Join the coalition
